- Citations, last 5 years
- 122.6k
- Works, last 5 years
- 18.9k
- h-index
- 824
- Scientists listed
- 0
- Grants since 2016
- 1 725
Grants received
2020–2025 · research · R01
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial
Barry W. Rovner · Thomas Jefferson University · funded by National Institutes of Health
2020–2024 · cooperative agreement · U01
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
Kerry S Campbell · Thomas Jefferson University · funded by National Institutes of Health
2020–2024 · fellowship · F30
Contribution of Zranb3 to normal and stressed hematopoiesis
Saul Kushinsky · Thomas Jefferson University · funded by National Institutes of Health
2020–2022 · research · R01
Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy
Bo Lu · Thomas Jefferson University · funded by National Institutes of Health
2020–2024 · research · R01
Defining the Role of West Nile Virus-Host Protein Interactions in Evading Antiviral Immunity
Holly Ramage · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Role of IL-7R in CNS autoimmunity
A.M. Rostami · Thomas Jefferson University · funded by National Institutes of Health
2020–2026 · research · R01
Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy
Bo Lu · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Early Life Environment Modifies Behavioral, Epigenetic, and Transcriptional Outcomes from Developmental Lead Exposure
Jay S Schneider · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
Renato V. Iozzo · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone
Bin Wang · Thomas Jefferson University · funded by National Institutes of Health
2020–2024 · research · R21
Exploring 3Dpol for RNA sequencing in real time
Ya-Ming Hou · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: A Randomized Clinical Trial
Barry W. Rovner · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
DC-subset-tailored vaccines
Botond Z Igyarto · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide
Bin Wang · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R35
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
Lin Guo · Thomas Jefferson University · funded by National Institutes of Health
2020–2023 · research · R01
Regulation of inositol trisphosphate receptors
Suresh K Joseph · Thomas Jefferson University · funded by National Institutes of Health
2020–2024 · research · R01
Mechanisms of RNA-DNA repair
Richard T Pomerantz · Thomas Jefferson University · funded by National Institutes of Health
2020–2024 · research · R01
tRNA-derived non-coding RNAs in ASM function and in asthma
Deepak A Deshpande · Thomas Jefferson University · funded by National Institutes of Health
2020–2024 · research · R01
Multifunctional Regulation of Prostate Cancer Metabolism by Sigma1 Modulators
Felix Jinhyun Kim · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer
Mathew Laxman Thakur · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Targeting the ubiquitin-proteasome pathway to reverse catabolic action of PTH in bone
Bin Wang · Thomas Jefferson University · funded by National Institutes of Health
2020–2026 · research · R01
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity
A.M. Rostami · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Development of an MRI Template & Neuroimaging Biomarkers of the Pediatric Spinal Cord
Laura Krisa · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R35
Elucidating the Mechanism in the Regulation of RNA-binding Protein Phase Separation
Lin Guo · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity
A.M. Rostami · Thomas Jefferson University · funded by National Institutes of Health
2020–2023 · grant · MRP
Using Cytomegalovirus to Modulate Tumor-Associated Macrophages and Drive Antitumor Immune Responses
Christopher Snyder · Thomas Jefferson University · funded by Congressionally Directed Medical Research Programs
2020–2025 · research · R35
tRNA in codon usage
Ya-Ming Hou · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Targeting the PTH1R Signaling Pathway for Osteoarthritis Therapy by a Novel Disruptor Peptide
Bin Wang · Thomas Jefferson University · funded by National Institutes of Health
2020–2025 · research · R01
Regulation of Axonal Transport At Branch Junctions
Le Ma · Thomas Jefferson University · funded by National Institutes of Health
2020 · research · PCF Challenge Award
PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry
Veda Giri · Thomas Jefferson University · funded by Prostate Cancer Foundation
2020 · fellowship · AACR-Ocular Melanoma Foundation Fellowship, in honor of Robert C. Allen, MD
Targeting metabolism as a therapeutic approach in uveal melanoma
Anna Han · Thomas Jefferson University · funded by American Association for Cancer Research
2020–2026 · research · R01
Investigating the Role and Regulation of the MAP7 Family Proteins in Axonal Morphogenesis and Function
Le Ma · Thomas Jefferson University · funded by National Institutes of Health
2020–2026 · research · R01
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium
Paula Bourke · Thomas Jefferson University · funded by National Institutes of Health
2020–2026 · research · R01
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
Matthias Johannes Schnell · Thomas Jefferson University · funded by National Institutes of Health
2020–2027 · research · R01
Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity
A.M. Rostami · Thomas Jefferson University · funded by National Institutes of Health
2020–2029 · research · R35
tRNA in codon usage
Ya-Ming Hou · Thomas Jefferson University · funded by National Institutes of Health
2020–2026 · research · R01
Role of IL-7R in CNS autoimmunity
A.M. Rostami · Thomas Jefferson University · funded by National Institutes of Health
2019–2023 · research · R01
Discovery of Gram-negative permeable chemical probes for tRNA methylation
Ya-Ming Hou · Thomas Jefferson University · funded by National Institutes of Health
2019–2024 · research · R35
Molecular Mechanisms of Mitochondrial Transcription and Replication
Dmitry Temiakov · Thomas Jefferson University · funded by National Institutes of Health
2019–2024 · research · R01
Pathogenesis of Inflammation-driven Intervertebral Disc Herniation: The Role of Syndecan 4
Makarand V Risbud · Thomas Jefferson University · funded by National Institutes of Health